Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies
Authors
Shattock, Andrew J.Benedikt, Clemens
Bokazhanova, Aliya
Duric, Predrag
Petrenko, Irina
Ganina, Lolita
Kelly, Sherrie L.
Stuart, Robyn M.
Kerr, Cliff C.
Vinichenko, Tatiana
Zhang, Shufang
Hamelmann, Christoph
Manova, Manoela
Masaki, Emiko
Wilson, David P.
Gray, Richard T.
Editors
Gupta, Ravindra KIssue Date
2017-02-16
Metadata
Show full item recordAbstract
Background Despite a non-decreasing HIV epidemic, international donors are soon expected to withdraw funding from Kazakhstan. Here we analyze how allocative, implementation, and technical efficiencies could strengthen the national HIV response under assumptions of future budget levels. Methodology We used the Optima model to project future scenarios of the HIV epidemic in Kazakhstan that varied in future antiretroviral treatment unit costs and management expenditure-two areas identified for potential cost-reductions. We determined optimal allocations across HIV programs to satisfy either national targets or ambitious targets. For each scenario, we considered two cases of future HIV financing: the 2014 national budget maintained into the future and the 2014 budget without current international investment. Findings Kazakhstan can achieve its national HIV targets with the current budget by (1) optimally reallocating resources across programs and (2) either securing a 35% [30%-39%] reduction in antiretroviral treatment drug costs or reducing management costs by 44% [36%-58%] of 2014 levels. Alternatively, a combination of antiretroviral treatment and management cost- reductions could be sufficient. Furthermore, Kazakhstan can achieve ambitious targets of halving new infections and AIDS-related deaths by 2020 compared to 2014 levels by attaining a 67% reduction in antiretroviral treatment costs, a 19% [14%-27%] reduction in management costs, and allocating resources optimally. Significance With Kazakhstan facing impending donor withdrawal, it is important for the HIV response to achieve more with available resources. This analysis can help to guide HIV response planners in directing available funding to achieve the greatest yield from investments. The key changes recommended were considered realistic by Kazakhstan country representatives.Citation
Shattock AJ, Benedikt C, Bokazhanova A, Đurić P, Petrenko I, Ganina L, et al. (2017) Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies. PLoS ONE 12(2): e0169530. https://doi.org/10.1371/journal.pone.0169530Publisher
Public Library of ScienceJournal
PLoS ONEPubMed ID
28207809 (pubmed)Additional Links
https://doi.org/10.1371/journal.pone.0169530Type
Journal articleLanguage
enDescription
© 2017 The Authors. Published by PLoS. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1371/journal.pone.0169530ISSN
1932-6203EISSN
1932-6203Sponsors
This study was funded by the World Bank Group and the Australian National Health and Medical Research Council (APP1064192 and APP1086540, both awarded to DPW). The World Bank Group also provided support in the form of salaries for CB and EM. The Kirby Institute at UNSW Australia is funded by the Australian Government, Department of Health and Ageing.ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0169530
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Licence for published version: Creative Commons Attribution 4.0 International
Related articles
- Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies.
- Authors: Shattock AJ, Benedikt C, Bokazhanova A, Đurić P, Petrenko I, Ganina L, Kelly SL, Stuart RM, Kerr CC, Vinichenko T, Zhang S, Hamelmann C, Manova M, Masaki E, Wilson DP, Gray RT
- Issue date: 2017
- Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
- Authors: Suraratdecha C, Stuart RM, Edwards M, Moore R, Liu N, Wilson DP, Albalak R
- Issue date: 2020
- Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
- Authors: Benedikt C, Kelly SL, Wilson D, Wilson DP, Optima Consortium
- Issue date: 2016 Dec
- The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
- Authors: Dutta A, Barker C, Kallarakal A
- Issue date: 2015 Nov